PURPOSE: Demonstrate applicability of natural D-glucose as a T2 MRI contrast agent. METHODS: D-glucose solutions were prepared at multiple concentrations and variable pH. The relaxation rate (R2 = 1/T2 ) was measured at 3, 7, and 11.7 T. Additional experiments were performed on blood at 11.7 T. Also, a mouse was infused with D-glucose (3.0 mmol/kg) and dynamic T2 weighted images of the abdomen acquired. RESULTS: The transverse relaxation rate depended strongly on glucose concentration and solution pH. A maximum change in R2 was observed around physiological pH (pH 6.8-7.8). The transverse relaxivities at 22°C (pH 7.3) were 0.021, 0.060, and 0.077 s(-1) mM(-1) at 3.0, 7.0, and 11.7 T, respectively. These values showed good agreement with expected values from the Swift-Connick equation. There was no significant dependence on glucose concentration or pH for T1 and the diffusion coefficient for these solutions. The transverse relaxivity in blood at 11.7 T was 0.09 s(-1) mM(-1) . The dynamic in vivo experiment showed a 10% drop in signal intensity after glucose infusion followed by recovery of the signal intensity after about 50-100 s. CONCLUSION: Glucose can be used as a T2 contrast agent for MRI at concentrations that are already approved for human use.
PURPOSE: Demonstrate applicability of natural D-glucose as a T2 MRI contrast agent. METHODS:D-glucose solutions were prepared at multiple concentrations and variable pH. The relaxation rate (R2 = 1/T2 ) was measured at 3, 7, and 11.7 T. Additional experiments were performed on blood at 11.7 T. Also, a mouse was infused with D-glucose (3.0 mmol/kg) and dynamic T2 weighted images of the abdomen acquired. RESULTS: The transverse relaxation rate depended strongly on glucose concentration and solution pH. A maximum change in R2 was observed around physiological pH (pH 6.8-7.8). The transverse relaxivities at 22°C (pH 7.3) were 0.021, 0.060, and 0.077 s(-1) mM(-1) at 3.0, 7.0, and 11.7 T, respectively. These values showed good agreement with expected values from the Swift-Connick equation. There was no significant dependence on glucose concentration or pH for T1 and the diffusion coefficient for these solutions. The transverse relaxivity in blood at 11.7 T was 0.09 s(-1) mM(-1) . The dynamic in vivo experiment showed a 10% drop in signal intensity after glucose infusion followed by recovery of the signal intensity after about 50-100 s. CONCLUSION:Glucose can be used as a T2 contrast agent for MRI at concentrations that are already approved for human use.
Authors: Todd C Soesbe; Matthew E Merritt; Kayla N Green; Federico A Rojas-Quijano; A Dean Sherry Journal: Magn Reson Med Date: 2011-05-23 Impact factor: 4.668
Authors: Kannie W Y Chan; Michael T McMahon; Yoshinori Kato; Guanshu Liu; Jeff W M Bulte; Zaver M Bhujwalla; Dmitri Artemov; Peter C M van Zijl Journal: Magn Reson Med Date: 2012-10-16 Impact factor: 4.668
Authors: Xiang Xu; Akansha Ashvani Sehgal; Nirbhay N Yadav; John Laterra; Lindsay Blair; Jaishri Blakeley; Anina Seidemo; Jennifer M Coughlin; Martin G Pomper; Linda Knutsson; Peter C M van Zijl Journal: Magn Reson Med Date: 2019-12-24 Impact factor: 4.668
Authors: Jiadi Xu; Kannie W Y Chan; Xiang Xu; Nirbhay Yadav; Guanshu Liu; Peter C M van Zijl Journal: Magn Reson Med Date: 2016-02-22 Impact factor: 4.668
Authors: David Ryoo; Xiang Xu; Yuguo Li; Joel A Tang; Jia Zhang; Peter C M van Zijl; Guanshu Liu Journal: Anal Chem Date: 2017-07-05 Impact factor: 6.986